Absci (ABSI) News Today → Log Into Marc's $5,000 System Today (From Chaikin Analytics) (Ad) Free ABSI Stock Alerts $4.27 +0.06 (+1.43%) (As of 05/28/2024 ET) Add Compare Share Share HeadlinesStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative May 28 at 4:24 PM | marketbeat.comPhoenix Venture Partners Ii Lp Sells 3,100,000 Shares of Absci Co. (NASDAQ:ABSI) StockAbsci Co. (NASDAQ:ABSI - Get Free Report) major shareholder Phoenix Venture Partners Ii Lp sold 3,100,000 shares of the company's stock in a transaction on Wednesday, May 22nd. The shares were sold at an average price of $4.40, for a total value of $13,640,000.00. Following the completion of the transaction, the insider now owns 11,279,522 shares of the company's stock, valued at $49,629,896.80. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at this link. Large shareholders that own 10% or more of a company's stock are required to disclose their sales and purchases with the SEC.May 28 at 8:00 AM | globenewswire.comAbsci to Participate in the Goldman Sachs 45th Annual Global Healthcare ConferenceMay 21, 2024 | marketbeat.comAbsci (NASDAQ:ABSI) Trading Up 2.8%Absci (NASDAQ:ABSI) Shares Up 2.8%May 18, 2024 | americanbankingnews.comAbsci Co. (NASDAQ:ABSI) to Post Q2 2024 Earnings of ($0.17) Per Share, HC Wainwright ForecastsMay 17, 2024 | marketbeat.comHC Wainwright Weighs in on Absci Co.'s Q2 2024 Earnings (NASDAQ:ABSI)Absci Co. (NASDAQ:ABSI - Free Report) - Analysts at HC Wainwright decreased their Q2 2024 earnings per share estimates for Absci in a research report issued on Wednesday, May 15th. HC Wainwright analyst S. Ramakanth now expects that the company will post earnings of ($0.17) per share for the quarMay 16, 2024 | seekingalpha.comAbsci: 'AI' Tag Keeping Company Afloat While Searching For Right FormulaMay 16, 2024 | investorplace.com7 Pharma Stocks Harnessing AI Brainpower for Big BreakthroughsMay 15, 2024 | markets.businessinsider.comBuy Rating Affirmed on AbSci’s Financial Stability and Lead Candidate ABS-101’s Market PotentialMay 15, 2024 | marketbeat.comAbsci (NASDAQ:ABSI) Releases Earnings Results, Misses Expectations By $0.03 EPSAbsci (NASDAQ:ABSI - Get Free Report) released its earnings results on Monday. The company reported ($0.22) earnings per share (EPS) for the quarter, missing analysts' consensus estimates of ($0.19) by ($0.03). Absci had a negative return on equity of 44.52% and a negative net margin of 1,933.65%. The company had revenue of $0.90 million during the quarter, compared to analysts' expectations of $2.50 million. During the same quarter in the previous year, the company earned ($0.26) EPS.May 15, 2024 | marketbeat.comAbsci (NASDAQ:ABSI) Earns Buy Rating from HC WainwrightHC Wainwright reaffirmed a "buy" rating and set a $7.00 target price on shares of Absci in a research report on Wednesday.May 15, 2024 | finance.yahoo.comAbsci Corp (ABSI) Q1 2024 Earnings Call Transcript Highlights: Strategic Advancements and ...May 14, 2024 | investorplace.comABSI Stock Earnings: Absci Misses EPS, Misses Revenue for Q1 2024May 14, 2024 | marketbeat.comAbsci (NASDAQ:ABSI) Shares Gap Down to $5.06Absci (NASDAQ:ABSI) Shares Gap Down to $5.06May 14, 2024 | globenewswire.comAbsci Reports Business Updates and First Quarter 2024 Financial and Operating ResultsMay 1, 2024 | marketbeat.comAbsci (NASDAQ:ABSI) Shares Up 8%Absci (NASDAQ:ABSI) Shares Up 8%April 23, 2024 | marketbeat.comAbsci (NASDAQ:ABSI) Shares Up 9.3%Absci (NASDAQ:ABSI) Stock Price Up 9.3%April 20, 2024 | finance.yahoo.comAbsci Corporation (ABSI)April 16, 2024 | finance.yahoo.comAbsci to Report Business Updates and First Quarter 2024 Financial and Operating Results on May 14, 2024April 9, 2024 | marketbeat.comAbsci (NASDAQ:ABSI) Reaches New 1-Year High at $6.52Absci (NASDAQ:ABSI) Sets New 52-Week High at $6.52April 8, 2024 | marketbeat.comAbsci (NASDAQ:ABSI) Stock Price Down 4%Absci (NASDAQ:ABSI) Stock Price Down 4%April 4, 2024 | marketbeat.comAbsci (NASDAQ:ABSI) Trading 5.6% Higher Absci (NASDAQ:ABSI) Trading Up 5.6%April 2, 2024 | marketbeat.comAbsci (NASDAQ:ABSI) Shares Gap Down to $5.61Absci (NASDAQ:ABSI) Shares Gap Down to $5.61March 28, 2024 | finance.yahoo.comAbsci to Participate in the 23rd Annual Needham Virtual Healthcare ConferenceMarch 27, 2024 | marketbeat.comAbsci (NASDAQ:ABSI) Trading Up 5.6%Absci (NASDAQ:ABSI) Stock Price Up 5.6%March 26, 2024 | marketbeat.comAbsci (NASDAQ:ABSI) Receives "Buy" Rating from Truist FinancialTruist Financial reiterated a "buy" rating and issued a $9.00 price objective on shares of Absci in a research report on Tuesday.March 25, 2024 | marketbeat.comAbsci's (ABSI) Outperform Rating Reiterated at ScotiabankScotiabank restated an "outperform" rating and set a $13.00 target price on shares of Absci in a research report on Monday.March 23, 2024 | finance.yahoo.comAbsci Corp (ABSI) Earnings: Misses Revenue Estimates and Reports Increased Net LossMarch 22, 2024 | markets.businessinsider.comBuy Rating Affirmed for AbSci: Promising Pipeline and Strategic Partnerships Signal GrowthMarch 22, 2024 | marketbeat.comAbsci (NASDAQ:ABSI) Given Buy Rating at HC WainwrightHC Wainwright restated a "buy" rating and set a $7.00 price objective on shares of Absci in a research report on Friday.March 22, 2024 | marketbeat.comAbsci (NASDAQ:ABSI) Issues Earnings ResultsAbsci (NASDAQ:ABSI - Get Free Report) released its quarterly earnings data on Thursday. The company reported ($0.25) EPS for the quarter, missing the consensus estimate of ($0.23) by ($0.02). Absci had a negative net margin of 1,535.13% and a negative return on equity of 38.14%. The business had revenue of $0.34 million during the quarter, compared to analysts' expectations of $1.75 million.March 21, 2024 | benzinga.comAbsci: Q4 Earnings InsightsMarch 21, 2024 | marketbeat.comAbsci (NASDAQ:ABSI) Trading Up 8.6%Absci (NASDAQ:ABSI) Trading 8.6% HigherMarch 21, 2024 | investorplace.comABSI Stock Earnings: Absci Misses EPS, Misses Revenue for Q4 2023March 21, 2024 | globenewswire.comAbsci Reports Business Updates and Fourth Quarter and Full Year 2023 Financial and Operating ResultsMarch 14, 2024 | marketbeat.comAbsci (NASDAQ:ABSI) Earns Sector Outperform Rating from Analysts at ScotiabankScotiabank began coverage on shares of Absci in a report on Thursday. They issued a "sector outperform" rating and a $13.00 target price for the company.March 13, 2024 | finance.yahoo.comABSI Apr 2024 6.000 callMarch 8, 2024 | marketbeat.comAbsci (NASDAQ:ABSI) Trading Up 9.2%Absci (NASDAQ:ABSI) Stock Price Up 9.2%March 7, 2024 | investing.comAbsci shares get buy rating, $9 target on AI biotech potentialMarch 6, 2024 | marketbeat.comAbsci (NASDAQ:ABSI) Stock Rating Reaffirmed by Truist FinancialTruist Financial reaffirmed a "buy" rating and issued a $9.00 price target on shares of Absci in a research note on Wednesday.March 4, 2024 | marketbeat.comAbsci (NASDAQ:ABSI) Shares Gap Up After Analyst UpgradeAbsci (NASDAQ:ABSI) Shares Gap Up Following Analyst UpgradeMarch 4, 2024 | marketbeat.comAbsci (NASDAQ:ABSI) Price Target Increased to $8.00 by Analysts at KeyCorpKeyCorp lifted their target price on Absci from $5.00 to $8.00 and gave the company an "overweight" rating in a report on Monday.March 1, 2024 | finance.yahoo.comAbsci Announces Closing of Public Offering of Common Stock Including Full Exercise of the Underwriters’ Option to Purchase Additional SharesMarch 1, 2024 | globenewswire.comAbsci Announces Closing of Public Offering of Common Stock Including Full Exercise of the Underwriters' Option to Purchase Additional SharesMarch 1, 2024 | marketbeat.comAbsci (NASDAQ:ABSI) Hits New 12-Month High at $5.53Absci (NASDAQ:ABSI) Sets New 1-Year High at $5.53February 28, 2024 | markets.businessinsider.comTD Cowen Keeps Their Buy Rating on AbSci (ABSI)February 28, 2024 | msn.comWhy Absci (ABSI) Shares Are FallingFebruary 28, 2024 | msn.comAbsci prices $75M equity offering at $4.50 per shareFebruary 27, 2024 | globenewswire.comAbsci Announces Pricing of Public Offering of Common StockFebruary 27, 2024 | globenewswire.comAbsci Announces Proposed Public Offering of Common StockFebruary 24, 2024 | ca.finance.yahoo.comCNC Mar 2024 86.000 call Get Absci News Delivered to You Automatically Sign up to receive the latest news and ratings for ABSI and its competitors with MarketBeat's FREE daily newsletter. Email Address Log Into Marc's $5,000 System Today (Ad)New Panic Could Sweep America Mark these words in 2024. Everyone's going to cash… Wall Street legend says: "A little-known vehicle outside of banks could double… triple… or even quadruple your life savings if you know where to find it right now." We urge you to move your cash into this vehicle in 2024. More here. ABSI Media Mentions By Week ABSI Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. ABSI News Sentiment▼1.090.87▲Average Medical News Sentiment ABSI News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. ABSI Articles This Week▼52▲ABSI Articles Average Week Get Absci News Delivered to You Automatically Sign up to receive the latest news and ratings for ABSI and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: OmniAb News Today ORIC Pharmaceuticals News Today MaxCyte News Today Taysha Gene Therapies News Today Orthofix Medical News Today COMPASS Pathways News Today SIGA Technologies News Today Altimmune News Today Pulse Biosciences News Today Y-mAbs Therapeutics News Today Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:ABSI) was last updated on 5/28/2024 by MarketBeat.com Staff From Our PartnersWARNING about the death of the U.S. dollar…Colonial MetalsDigitizing the $11T commodities sector with one tiny stockResource Stock DigestTim Sykes’ Urgent Trade Alert: “Make this move now”Timothy SykesBiggest Prediction of My 50-Year Career on Wall StreetChaikin AnalyticsElon’s New Device is About to Shock the WorldInvestorPlaceHe Is Giving Away BitcoinCrypto Swap ProfitsExposed: 10 CENT Crypto to Explode May 20th?True Market InsidersThe ONE AI Stock to own now. (It’s not Nvidia.)Weiss Ratings Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Absci Co. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
